This model will facilitate further characterization of the mechanisms by which tumoral Foxp1 depletion can restore immune surveillance and offers an opportunity to investigate the potential of this approach to enhance the response to immune checkpoint inhibitors in DLBCL. Here, FOXP1 is linked to diffuse large B-cell lymphoma.